Skip to main content

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, video visits and more. Learn More >>

Location

Texas Medical Center

Specialty
Pathology
Phone: 832-824-2250
Fax: 832-825-1032

Address

6621 Fannin Street
Suite AB1195
Houston, TX 77030

Adekunle Michael Adesina, MD, PhD

Medical Director of Neuropathology, Molecular Neuropathology and Global Pathology

Texas Children's Hospital
Professor of Pathology & Immunology and Pediatrics, Baylor College of Medicine

Education

School Education Degree Year
McGill University, Montreal, Canada PhD Doctor of Philosophy 1997
Fox Chase Cancer Center Residency Pathology 1994
McGill University Faculty of Medicine Professional Education Molecular & Human Genetics 1992
Montreal General Hospital-Canada Fellowship Research Fellowship 1992
Albert-Ludwigs University Fellowship 1991
University of Vermont Residency Pathology 1990
University of Ibadan Residency Anatomic Pathology 1986
University of Ibadan Internship Senior House Officer 1981
University of Ibadan Medical School Bachelor of Medicine & Surgery 1980

About

Dr. Adesina's primary interest is in the clinical and molecular genetics of pediatric brain tumors with special interest in medulloblastoma. He is involved in ongoing collaborative studies with the pediatric brain tumor group of the Hematology/Oncology division. He is also a collaborator with others on the genomic profiling of embryonal pediatric tumors and the role of FoxG1 in determining susceptibility to these embryonal tumors.

Organizations

Organization Name Role
American Association for the Advancement of Science Member
American Association of Neuropathologists Member
Anatomic Pathology and Molecular Pathology, College of American Pathologists Inspector
Association for Molecular Pathology Member
College of American Pathologists and Archives of Pathology and Laboratory Medicine Associate Editor

Selected Publications

Li JY, Langford LA, Adesina A, Bodhireddy SR, Wang M, Fuller GN. The high mitotic count detected by phospho-histone H3 immunostain does not alter the benign behavior of angiocentric glioma. Brain Tumor Pathology 2012 Jan;29(1):68-72.

View All Publications

* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.